Eric Lawitz
- Hepatology top 0.02%
- Hepatitis C virus research 197
- Liver Disease and Transplantation 39
- Liver Diseases and Immunity 27
- Epidemiology top 0.05%
- Liver Disease Diagnosis and Treatment 173
- Hepatitis B Virus Studies 97
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 60
- Cancer Research top 1%
-
- Systemic Lupus Erythematosus Research 29
-
- Chronic Lymphocytic Leukemia Research 25
- Co-authors
- John G. McHutchisonFred PoordadStefan ZeuzemM. Rodríguez‐TorresStuart C. GordonBruce R. BaconClifford A. BrassJanice K. Albrecht
- Partner nations
- United StatesFranceGermany
In The Last Decade
Eric Lawitz
296 papers receiving 15.9k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Hepatology 11.0k
- Epidemiology 11.6k
- Infectious Diseases 2.6k
- Endocrinology, Diabetes and Metabolism 1.7k
- Cancer Research 1.4k
Countries citing papers authored by Eric Lawitz
This map shows the geographic impact of Eric Lawitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lawitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lawitz more than expected).
Fields of papers citing papers by Eric Lawitz
This network shows the impact of papers produced by Eric Lawitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lawitz. The network helps show where Eric Lawitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Lawitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 8 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 34 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 47 | |
| 10 | 2022 | 73 | |
| 11 | 2021 | 87 | |
| 12 | 2020 | 42 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 9 | |
| 15 | 2018 | 74 | |
| 16 | 2014 | 12 | |
| 17 | 2014 | 5 | |
| 18 | 2013 | 5 | |
| 19 | FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA | 2011 | 12 |
| 20 | 2009 | 5 |
About Eric Lawitz
Eric Lawitz is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Genetics and Rheumatology, having authored 317 papers that have together received 16.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (197 papers), Liver Disease Diagnosis and Treatment (173 papers), Hepatitis B Virus Studies (97 papers), HIV/AIDS drug development and treatment (60 papers), Liver Disease and Transplantation (39 papers), Systemic Lupus Erythematosus Research (29 papers), Liver Diseases and Immunity (27 papers) and Chronic Lymphocytic Leukemia Research (25 papers). The work is most often cited by research in Hepatology (11.0k citations), Epidemiology (11.6k citations), Infectious Diseases (2.6k citations), Endocrinology, Diabetes and Metabolism (1.7k citations) and Cancer Research (1.4k citations). Eric Lawitz has collaborated with scholars based in United States, France and Germany. Frequent co-authors include John G. McHutchison, Fred Poordad, Stefan Zeuzem, M. Rodríguez‐Torres, Stuart C. Gordon, Bruce R. Bacon, Clifford A. Brass, Janice K. Albrecht, Rohit Loomba and Zachary Goodman. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, The American Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.